Brought to you by 
Express Scripts pays $4.7bn for WellPoint's NextRx business
15 Apr 2009
Executive Summary
Express Scripts announced it will acquire health plan administrator WellPoint's three NextRx pharmacy benefit management subsidiaries--NextRx Inc., NextRx Services Inc., and NextRx LLC--for $4.7bn, or approximately $3.3bn cash plus $1.4bn in Express common stock (based on the market average, this could mean about 29.4mm shares). Express is financing the transaction using money from a debt sale.
Deal Industry
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Express Scripts pays $4.7bn for WellPoint's NextRx business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice